Literature DB >> 2713662

Respiratory effects of 5'-ethylcarboxamidoadenosine, an analog of adenosine, following microinjections into the nucleus tractus solitarius of rats.

R A Barraco1, C A Janusz.   

Abstract

Microinjections of 5'-ethylcarboxamidoadenosine (NECA), an adenosine analog, were made into respiratory-related regions of the nucleus tractus solitarius (NTS) of spontaneously breathing rats and cardiorespiratory parameters were recorded during a 60-min test period. Microinjections of NECA, in the dose range of 0.35-350 picomol per rat, produced significant dose-related reductions in respiratory rate which were accompanied by correlative increases in tidal volume. At the end of the 60-min test period following the administration of NECA, the respiratory rate remained profoundly depressed, whereas blood pressure and heart rate were not significantly affected compared to preinjection control values. The data from this study suggest that adenosine may exert modulatory influences in brainstem respiratory control regions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2713662     DOI: 10.1016/0006-8993(89)90208-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  Neural mechanisms of swallowing: neurophysiological and neurochemical studies on brain stem neurons in the solitary tract region.

Authors:  B J Sessle; J L Henry
Journal:  Dysphagia       Date:  1989       Impact factor: 3.438

2.  Action of adenosine receptor antagonists on the cardiovascular response to defence area stimulation in the rat.

Authors:  J H St Lambert; M S Dawid-Milner; L Silva-Carvalho; K M Spyer
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

3.  Adenosine-A2A Receptor Signaling Plays a Crucial Role in Sudden Unexpected Death in Epilepsy.

Authors:  Hai-Ying Shen; Sadie B Baer; Raey Gesese; John M Cook; Landen Weltha; Shayla Q Coffman; Jie Wu; Jiang-Fan Chen; Ming Gao; Teng Ji
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.